Chronic myelogenous leukemia: a case report from Azal Hospital, Sana'a, Yemen

الشريط الجانبي للمقالة

Retinal haemorrhag
PDF New (الإنجليزية)
منشور: 2024-11-04
DOI: https://doi.org/10.59628/jchm.v18i4.1330
الكلمات المفتاحية:
Chronic myeloid leukaemia (CML), Imatinib, hydroxyurea.

محتوى المقالة الرئيسي

Adnan Al-Adhal
Department of Medicine, Faculty of Medicine and clinical Sciences, Sana’a University, Sana’a Yemen. Department of Pharmacology, Faculty of Medicine and clinical Sciences, Sana’a University, Sana’a Yemen. Azal hospital, Sana'a, Yemen.
Ahmed Qayed Salem
Department of Medicine, Faculty of Medicine and clinical Sciences, Sana’a University, Sana’a Yemen
Najeeb Muthanna
Azal hospital, Sana'a, Yemen
Asmaa Alwan
Department of Pharmacology, Faculty of Medicine and clinical Sciences, Sana’a University, Sana’a Yemen

الملخص

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder that is always associated with the presence of the BCR-ABL gene. In this article, we report the case of a 38-year-old male patient who presented with fever, fatigue, abdominal pain, and blurred vision. Investigations confirmed CML with leukemic-like retinal hemorrhages and anemia. The patient was immediately given imatinib 400 mg daily for 2 weeks, and then hydroxyurea 500 mg daily was added. After 4 months, the white blood cells, hemoglobin, and basophils returned to normal values, the retinal hemorrhages improved, and the patient's general health improved.

تفاصيل المقالة

إصدار

مجلد 18 عدد 4 (2024): مجلة جامعة صنعاء للطب والعلوم الصحية

القسم

المقالات
Creative Commons License

هذا العمل مرخص بموجب Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

كيفية الاقتباس

Chronic myelogenous leukemia: a case report from Azal Hospital, Sana’a, Yemen. (2024). مجلة جامعة صنعاء للطب والعلوم الصحية, 18(4), 91-93. https://doi.org/10.59628/jchm.v18i4.1330

المراجع

المؤلفات المشابهة

يمكنك أيضاً إبدأ بحثاً متقدماً عن المشابهات لهذا المؤلَّف.

الأعمال الأكثر قراءة لنفس المؤلف/المؤلفين